Aspirina Case Instructive For Trademark Practitioners
The court’s opinion, as well as the TTAB’s underlying Order (2005 WL 3395183 (TTAB Dec. 1, 2005)) (“TTAB Order”), prove instructive to trademark practitioners on a variety of issues, as discussed below in Section II.
* Summary of Decision and Dissent *
Bayer AG (“Bayer”) applied to register Aspirina for...
To view the full article, register now.